close icon

Three Months Ahead of NovoCure ‘s 35% Plunge

Our first and only article on NovoCure stock was published almost three months ago, on July 1st. In it we shared our view that the tumor treatment company was not only significantly overvalued, but in immediate danger of a large stock price drop.

The stock had just fell 15% in one day, despite positive TTFields liver cancer study results. Given the company’s promise, however, most investors saw this dip as a buying opportunity. We, on the other hand, after taking a look at the Elliott Wave chart below, thought NVCR can quickly lose another 40%.

NovoCure Poised for a Significant Drop

NovoCure ‘s daily chart revealed a complete five-wave impulse pattern, labeled I-II-III-IV-V. According to the theory, every impulse is followed by a correction, which usually erases the entire fifth wave. Hence, instead of joining the bulls near $190 a share, we expected “more weakness towards ~$120.” As it turned out, we didn’t have to wait too long for this bearish setup to bear fruit.

NVCR cut in half in three months

NovoCure stock just kept falling. Last week, it plunged to barely above $123 a share, down 35% since we wrote about it and almost 50% from its June record. The gains achieved by wave V have been almost entirely erased. However, we still don’t think it is time to invest in NVCR stock.

50% Crash Still Not Enough to De-Risk NovoCure Stock

Corrections consist of three waves, not one. The recent selloff, even though it reached our initial target area, doesn’t look like a complete retracement. It makes more sense to label it as just a first wave – A – of a simple A-B-C zigzag still in progress. This would mean a recovery in wave B, followed by more weakness in wave C, can be anticipated. Let’s try to confirm this with the help of the 4-hour chart below.

NovoCure draws an impulse pattern to the downside

NovoCure ‘s 4h chart depicts not only the impulsive structure of wave V, but also that the following crash is also a five-wave pattern. Wave A is marked 1-through-5, where the five sub-waves of wave 3 are visible, as well. This strengthens our conviction that the bears are still not done with NVCR stock yet.

Wave B can lift the price to $160 and even $190. Alas, the bulls’ optimism is likely to be short-lived as another plunge to under $100 would be around the corner. Besides, even after the recent crash de-risked NovoCure somewhat, the company is still trading at price-to-sales ratio of 24.

Similar Elliott Wave setups occur in the Forex, crypto and commodity markets, as well. Our Elliott Wave Video Course can teach you how to uncover them yourself!

Stay informed with our newsletter

Latest Elliott Wave analysis on different topics delivered to you weekly.

Privacy policy
You may also like:

Dell Stock Trading in Fifth and Final Wave

Investors who were brave or fortunate enough to buy Dell Technologies during the coronavirus panic of March 2020 must be very pleased with the results. The stock is up 338% from that bottom at $25.51 and closed at $111.63 yesterday. For a profitable, growing and financially sound company like Dell, that surge is not a…

Read More »

Has ServiceNow ‘s Bubble Finally Reached its Limit?

After the huge success of Amazon Web Services, it is easy to see why cloud computing is such a hot sector right now. However, no trend lasts forever and no stock remains a Wall Street darling indefinitely. Today, we’d like to examine another red-hot company in the cloud industry – ServiceNow Inc. With a market…

Read More »

Megacable Stock – A Pattern 13 Years in the Making

Megacable Holdings engages in the provision of telecom services to 250 cities in 25 states in Mexico. Headquartered in Guadalajara, the company was founded in 1982 but did not go public before late-2007. Listing on a public market in 2007 practically guaranteed terrible stock performance over the next year or so during the global Financial…

Read More »

GN Store Nord Stock On Its Way to the Bargain Bin

In case you didn’t know, GN Store Nord A/S is a leading hearing aid devices manufacturer, based in Denmark. The company’s annual sales are expected to exceed DKK 15 billion this year. According to Statista, GN held a 15% share of the global hearing aid device market in 2019. Considering that its growth rate has…

Read More »

Roku Down 37% as Elliott Wave Correction Unfolds

We last wrote about Roku in the spring, on May 24th, 2021. The stock was hovering around $330 a share. Fundamentally speaking, we thought that even this was too high a price. A quick look on the company’s weekly chart, however, convinced us that “Roku ‘s bubble can keep inflating”. Not indefinitely, though. The anticipated…

Read More »

MongoDB – Bearish Pattern Joins Nosebleed Valuation

MongoDB Inc. is a general purpose database platform developer and provider. The company was founded in 2007, but only came public ten years later – in 2017. During the following four years, the stock has risen from an IPO price of $33 to $515 a share as of last week. So, it is fair to…

Read More »

Pandora Does Things Right. Stock May Need a Breather

When we wrote our previous article on Danish jewelry maker Pandora in December, 2020, the stock was up over three-fold since March. That recovery from DKK 180 to DKK 651 didn’t not come out of the blue, though. It was the result of a bullish setup we managed to identify as early as July 2019.…

Read More »

More analyses